EverSonix

ADVANCED PAIN MANAGEMENT: NO SURGERY. NO OPIOIDS. JUST RESULTS.

EverSonix

has created a novel medical device, providing advanced pain treatment for upwards of 30 million Americans living in pain caused by damage or dysfunction in the nervous system. Our device uses ultrasound-based technology to disrupt pain signals en route to the brain. With just a 3-minute ultrasound treatment, LoFUS has been shown to provide up to 30 days of pain relief in animal models. LoFUS will provide patients with a cost-effective solution without the risk of opioid addiction or the need for needles, while creating a repeatable revenue stream for hospitals.

~77 million Americans seek treatment for lower back pain; 10 million people have high-impact sciatic pain.

52.4 cases/1,000 persons/year, chronic pain incidence is greater than that of diabetes, depression, and hypertension.

62% with no relief, the incidence of people with chronic pain in 2019 reported no relief within a year.

High Cost: >$500B in healthcare costs/lost wages per year due to chronic pain.

The Problem

Existing pain solutions fall short, leaving 40% of patients with insufficient relief and major side effects. Currently, the best solutions available involve opioids, injections, and/or invasive medical devices/procedures. What if we had a repeatable solution to disrupt pain signals without the need for needles, drugs, incisions, and with no side effects? It is time for a novel approach to pain therapy.

Our Solution

LoFUS is the first medical device to successfully modulate or “turn down” the pain signal at the central nervous system without surgery, injections, or drugs. It is a proprietary solution with an ultrasound applicator that delivers ultrasound waves to a treatment zone personalized for each patient’s anatomy. LoFUS is the only non-surgical way to disrupt spinal pain signals without damaging tissue or nerves.

The LoFUS solution for neuropathic pain.